Introduction: The da Vinci Single-Port (SP) robotic system represents a newer minimally invasive surgical development with greater articulation and reduced surgical footprint through the use of a single incision. While originally applied in urology and otolaryngology, its application in general surgery is on the rise. This review aims to delineate the current applications, outcomes, and limitations of the SP platform in general surgical procedures. Methods: A descriptive literature search of PubMed, Scopus, and Embase databases was conducted to identify relevant peer-reviewed studies up to September 2025. The included studies reported SP robotic surgeries in various fields of general surgery. Results: A growing body of literature was found that reports the safety and feasibility of SP robotic surgery within general surgery. Advantages reported include improved cosmesis, decreased postoperative pain, and shorter recovery time. The present evidence is largely made up of small case series and initial feasibility studies. Technical drawbacks, such as crowding of instruments and a learning curve, remain issues. Conclusions: The da Vinci SP system shows promising potential for application in general surgery, particularly for certain procedures. Additional prospective studies and larger case series need to outline its long-term results, cost-effectiveness, and optimal indications.

Robotic pancreaticoduodenectomy (RPD) has emerged as a viable alternative to open and laparoscopic approaches, offering potential advantages in precision and dexterity. However, its complexity and lack of standardization remain as barriers to widespread adoption. We present a step-by-step surgical approach to RPD, emphasizing key technical strategies to enhance safety, efficiency, and reproducibility. Our technique is structured into defined surgical steps, facilitating learning curve optimization and intraoperative consistency. Key refinements include an optimized trocar placement, the strategic suspension of vascular structures, and specific reconstructive techniques to reduce the operative time and improve surgical ergonomics. These improvements may contribute to a reduction in perioperative morbidity and procedural standardization. Standardizing RPD through defined surgical steps and structured learning pathways may improve its feasibility, safety, and broader adoption. Further studies are needed to validate these strategies in high-volume centers.

Background: Robotic pancreaticoduodenectomy (RPD) is a less invasive alternative to open pancreaticoduodenectomy (OPD) with the potential for perioperative advantage. Concerns remain regarding its technical difficulty, cost, and oncologic adequacy. Methods: Review of PubMed, MEDLINE, Scopus, and Embase databases was conducted (January 2000–October 2025), focusing on systematic reviews, meta-analyses, and significant comparative studies of RPD. Outcomes assessed were perioperative outcomes, oncologic sufficiency, learning curve, model training, cost-effectiveness, and future developments. Results: Several studies report comparable R0 rates and lymph node yield between RPD and OPD, with reduced blood loss, shorter postoperative hospital stay, and faster recovery in high-volume centers. Morbidity (35–50%) and 90-day mortality (<2%) are similar to open or laparoscopic surgery. Competence is usually achieved after 40–60 cases, while optimal outcomes are achieved after 80–100 procedures. Structured mentorship and simulation training improve safety and reproducibility. Novel technologies such as augmented reality, intraoperative fluorescence, and artificial intelligence-based navigation may also enhance accuracy and shorten the learning curve. Conclusions: RPD appears to be a safe and effective minimally invasive option in carefully selected patients if done in specialized, high-volume centers. Future studies need to resolve long-term oncologic results, cost-effectiveness, and the role of next-generation robotic systems.

Introduction: Common bile duct (CBD) exploration is indicated in symptomatic patients with choledocholithiasis when endoscopic retrograde cholangiopancreatography (ERCP) is not feasible or has failed. In selected complex cases, robotic surgery may offer technical advantages over conventional laparoscopy. Material and Methods: A 51-year-old woman presented with biliary colic and ultrasound evidence of choledocholithiasis. Past medical history included congenital pyloric stenosis treated with open gastrojejunostomy at the age of 3 days, precluding ERCP. Magnetic resonance cholangiopancreatography (MRCP) and percutaneous transhepatic cholangiography (PTC) demonstrated multiple large distal CBD stones. Interventional radiology attempts failed to achieve complete clearance, and a percutaneous biliary drain was placed. The patient underwent robotic-assisted cholecystectomy and CBD exploration. Results: Following extensive adhesiolysis, robotic cholecystectomy was completed. A longitudinal choledochotomy enabled extraction of multiple stones using the chopstick technique, a Fogarty catheter, and choledochoscopic basket retrieval. After unsuccessful conventional retrieval attempts, an impacted stone was removed using a choledochoscopy-guided robotic intraductal grasping maneuver, with an 8-mm wristed forceps introduced through the choledochotomy and used exclusively for mechanical grasping. The choledochotomy was closed with continuous suturing, and intraoperative cholangiography confirmed unobstructed biliary flow without residual stones. The postoperative course was uneventful, and the patient was discharged on postoperative day seven. At two-month follow-up, cholangiography through the transcystic catheter confirmed persistent ductal clearance, allowing for catheter removal. Conclusions: This case demonstrates the feasibility of robotic CBD exploration in a selected patient with complex choledocholithiasis and altered anatomy when conventional treatment options were not feasible or unsuccessful.